Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
Frank Cichocki, Sjoukje J. C. van der Stegen, Jeffrey S. Miller
Blood (2022) Vol. 141, Iss. 8, pp. 846-855
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
G. Ahmad, Samaneh Nouri, Amirhossein Mohammad Gholian, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118071-118071
Closed Access
A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy
Gustavo Rodrigues Rossi, Jane Sun, Cheng‐Yu Lin, et al.
Immunology and Cell Biology (2024)
Open Access | Times Cited: 3
Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells
Yue Qin, Qi Cui, Guihua Sun, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114867-114867
Open Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
‘Off the shelf’ immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells
Chenxin Wang, Jingjing Liu, Wei Li
Cell Proliferation (2023) Vol. 56, Iss. 4
Open Access | Times Cited: 9
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e007886-e007886
Open Access | Times Cited: 2
Tuning CAR T-cell therapies for efficacy and reduced toxicity
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 333-344
Closed Access | Times Cited: 2
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
Peiwen Ma, Yale Jiang, Zhao Guo, et al.
European Journal of Cancer (2024) Vol. 209, pp. 114224-114224
Closed Access | Times Cited: 2
Revolutionizing Cancer Treatments through Stem Cell-Derived CAR T Cells for Immunotherapy: Opening New Horizons for the Future of Oncology
Hemant K. Mishra, Alex Kalyuzhny
Cells (2024) Vol. 13, Iss. 18, pp. 1516-1516
Open Access | Times Cited: 2
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery
Emma McErlean, Helen O. McCarthy
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Bispecific antibodies for multiple myeloma: past, present and future
Toshiki Ochi, Tatsuya Konishi, Katsuto Takenaka
International Journal of Hematology (2024) Vol. 120, Iss. 1, pp. 23-33
Closed Access | Times Cited: 1
A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy
Niraj Shrestha, Michael J. Dee, Pallavi Chaturvedi, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 9
Open Access | Times Cited: 1
Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells
Jongsuk Han, Hyeongbin Son, Daun Jung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8209-8209
Open Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
iPSC‐derived NK cells with site‐specific integration of CAR19 and IL24 at the multi‐copy rDNA locus enhanced antitumor activity and proliferation
Yuxuan Zhang, Qingxin Shi, Peiyun Wang, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access
Advancing Cancer Immune Cell Therapies via Engineered iPSC-Based Strategies
Son Hai Vu, Xuan‐Hung Nguyen
Interdisciplinary cancer research (2024)
Closed Access
Antitumor effects of natural killer cells derived from gene-engineered human induced pluripotent stem cells on hepatocellular carcinoma
Mayuna Nakamura, Yuka Tanaka, Keishi Hakoda, et al.
Research Square (Research Square) (2024)
Open Access
Generation of ex vivo autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy
Kajornkiat Maneechai, Wannakorn Khopanlert, Panarat Noiperm, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38447-e38447
Open Access
Engineered Cellular Therapies for the Treatment of Thoracic Cancers
Spencer M Erickson, Benjamin M. Manning, Akhilesh Kumar, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 35-35
Open Access
Next frontier in cancer treatment: an iPSC supported CAR-T cell therapies
Tayyaba Sona
Asia-Pacific Journal of Oncology (2024)
Open Access
Previous Page - Page 2

Scroll to top